2BB score and signals
BridgeBio Pharma, Inc.’s current 2BB score is 66 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 81 | Very High |
| Momentum | 75 | Improving |
| Financial strength | 33 | Weak |
| Quality | 97 | Very Strong |
| Risk | 62 | High |
Company facts
| CEO | Neil Kumar |
| Headquarters | Palo Alto, California, United States |
| Founded | 2015 |
| Employees | 1K |
| 52-week range | $52.75 – $93.42 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-10-29 | — | -0.6523 | — | $275.64M |
| 2026-08-10 | -0.78 | -0.5951 | $243.68M | $223.12M |
| 2026-05-07 | -0.84 | -0.6921 | $194.51M | $181.50M |
| 2026-02-24 | -1.0 | -0.757 | $154.18M | $149.78M |
Related companies
2BBBullish & Bearish